For research use only. Not for therapeutic Use.
CPD-1224（Cat No.:I041278）is an experimental small molecule compound being explored for its potential therapeutic applications in oncology and autoimmune diseases. It acts as a selective inhibitor of specific protein targets involved in cell signaling pathways that regulate immune responses and cancer cell proliferation. CPD-1224 has shown promise in preclinical studies for its ability to inhibit tumor growth and modulate immune system activity, potentially enhancing the body’s ability to target cancer cells. Research is ongoing to assess its efficacy, safety, and therapeutic potential, with a focus on developing it as a targeted treatment for various diseases.
| CAS Number | 2891620-68-9 |
| Synonyms | 5-[3-[[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-5-methoxy-2-methylphenyl]piperidin-1-yl]methyl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| Molecular Formula | C43H47ClN8O7S |
| Purity | ≥95% |
| IUPAC Name | 5-[3-[[4-[4-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-5-methoxy-2-methylphenyl]piperidin-1-yl]methyl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| InChI | InChI=1S/C43H47ClN8O7S/c1-24(2)60(57,58)37-8-6-5-7-33(37)46-39-32(44)20-45-43(49-39)47-34-17-25(3)30(19-36(34)59-4)27-13-15-50(16-14-27)21-26-22-51(23-26)28-9-10-29-31(18-28)42(56)52(41(29)55)35-11-12-38(53)48-40(35)54/h5-10,17-20,24,26-27,35H,11-16,21-23H2,1-4H3,(H,48,53,54)(H2,45,46,47,49) |
| InChIKey | YROLXKJYDUJWRK-UHFFFAOYSA-N |
| SMILES | CC1=CC(=C(C=C1C2CCN(CC2)CC3CN(C3)C4=CC5=C(C=C4)C(=O)N(C5=O)C6CCC(=O)NC6=O)OC)NC7=NC=C(C(=N7)NC8=CC=CC=C8S(=O)(=O)C(C)C)Cl |
